ASCO: Abiraterone Extends Survival in Metastatic Prostate CA
Side effects noted with use of abiraterone similar to those already found in patients taking the drug
Model Predicts Acute GI Bleeding in Anticoagulated Patients
New scoring model includes five factors predictive of GI bleeding in patients taking oral anticoagulants
Reducing SBP Targets Below Current Guidelines Cuts Risk
Reducing SBP to 120 to 124 mm Hg linked to reduced risk of cardiovascular disease, all-cause mortality
Cool Water Works As Well As Hot for Ridding Hands of Germs
Time spent scrubbing hands with soap more important that water temperature
2011 to 2014 Saw Increase in Use of High-Intensity Statins After MI
Increase in percentage of beneficiaries whose first statin Rx after MI was for high-intensity dose
Short-Term Benefits for Immunotherapy in Allergic Asthma
Reductions seen in short-term symptom scores and medication scores, with evidence of publication bias
MTHFR A1298C Polymorphism Not Linked to MTX Outcomes in RA
No significant link for MTHFR gene A1298C polymorphism with methotrexate efficacy, toxicity
Substantial Increase in Costs With Metastases in Prostate CA
Costs peak during month of metastases diagnosis, reaching $13,291
May 2017 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for May 2017. This roundup includes the latest...
β-Blocker Use Not Linked to Reduced Mortality After AMI
No significant difference in mortality for MI patients without HF, LVSD with, without β-blocker use
